Long Focus Capital Management’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
BGI
NAMI
Long Focus Capital Management's CLLS Position: Q1 2026 in Review
Long Focus Capital Management reduced its Cellectis (CLLS) stake by 1.6% in Q1 2026, selling an estimated $167K and leaving 2,744,098 shares worth $8.7M. The position accounts for 0.23% of the portfolio, ranked #71.
Long Focus Capital Management first reported a position in CLLS in Q4 2021 and has held it in 18 quarters since. The position peaked at $13.8M in Q4 2023. 32 funds tracked by Wall St. Rank hold CLLS as of Q1 2026.
- Long Focus Capital Management held 2,744,098 shares of Cellectis worth $8.7M as of Q1 2026.
- Long Focus Capital Management sold 43,652 Cellectis shares in Q1 2026, an estimated $167K.
- Cellectis made up 0.23% of Long Focus Capital Management's portfolio in Q1 2026, its #71 holding.
- Long Focus Capital Management first reported a position in Cellectis in Q4 2021 and has held it in 18 quarters since.
- Long Focus Capital Management's Cellectis position peaked at $13.8M in Q4 2023.
- 32 funds tracked by Wall St. Rank held Cellectis as of Q1 2026.
Based on Long Focus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.